This is a heading for an Event Header block
This is a description for an Event Header block.
Sidebar #1 – Old
-
Heading
Francis Fontan Fund
Text
Event Information 3 this is a longer title that would go over a few lines
-
This is a heading
General Information
Here is some text. Here is some text. Here is some text. Here is some text. Here is some text. Here is some text. Here is some text.
This is test content inside the Event Header.
Summit programme
| 08:00 | Welcome and Introduction Färber, Homburg; Falk, Berlin; Zimpfer, Vienna; Gummert, Bad Oeynhausen |
| 08:15 | Session 1: New opportunities in non-invasive cardiology |
| Moderators: F Schönrath, J Stehlik, C Engin | |
| Update of optimal medical therapy and device treatment (OMDT) N Uriel, New York |
|
| Glucagon-like peptide-1 (GLP-1) receptor agonists for everybody and forever N Pavo, Vienna |
|
| GLP-1 receptor agonists for those who need them M Adamo, Brescia |
|
| The concept of a wonder drug – take and forget U Jorde, New York |
|
| Panel discussion | |
| 09:30 | Break |
| 10:00 | Session 2: Happy life on durable MCS |
| Moderators: J Mulzer, I Hilgendorf, M Kanwar | |
| Interventions on left ventricular assist device (LVAD) – and they live happily ever after? J Stehlik, Salt Lake City |
|
| Cancer treatment in LVAD patients – is everything possible? W Schöning, Berlin |
|
| Transcatheter aortic valve implantation (TAVI) and transcatheter edge-to-edge repair (TEER) on LVAD H Hinkov, Berlin |
|
| LVAD till the end? Palliative care F Calvo, Mailand |
|
| Psychosocial care – patient and caregiver K Schmitt, Berlin |
|
| Panel discussion | |
| 11:30 | Session 3: Invited discussion – big data and AI in medicine |
| Moderators: R Lorusso, I Potapov, I Just-Lauer | |
| Scientific base for AI – I or A? A Bryutkin, Boston |
|
| AI from the clinical perspective A Meyer, Berlin |
|
| Panel discussion | |
| 12:30 | Lunch |
| 13:30 | Session 4: MCS registries |
| Moderators: J Möller, G Nersesian | |
| Scientific evaluation of MCS registries vs multicentre studies N Uriel, New York |
|
| Cardiogenic shock working group register M Kanwar, Chicago |
|
| IMCARS B Niemann, Giessen |
|
| EUROMACS P Quattroni, Windsor |
|
| INTERMACS M Kanwar, Chicago |
|
| IMACS D Goldstein, New York |
|
| Stellar register S Rojas Hernandez, Bad Oeynhausen |
|
| PediMACS/ACTION I Adachi, Houston |
|
| Panel discussion | |
| 15:00 | Break |
| 15:30 | Session 5: Different phenotypes of cardiogenic shock: Interactive male case discussion |
| Moderators: P Lanmüller, P Ivak, F Khaleil | |
| SCAI and INTERMACS stages – how to calculate, compare and use in clinical practice M Kanwar, Chicago |
|
| Acute myocardial infarction J Möller, Denmark |
|
| Postcardiotomy R Lorusso, Maastricht |
|
| Acute on chronic heart failure U Schneider, Würzburg |
|
| Fulminant myocarditis C Chiu, Berlin |
|
| Panel discussion | |
| 16:30 | Session 6 – EACTS /ICCAC joint session: LVAD therapy – how to make the most out of it? |
| Moderators: F Müller, T Schlöglhofer, C Engin | |
| The power of networking F Müller, Homburg |
|
| Patient evaluation, selection and optimisation – can we do better? J Gummert, Bad Oeynhausen |
|
| LVAD and beyond – novel tools and useful wearables S Kore, Manchester |
|
| Long-term LVAD perspectives – incredible patients and unforgettable scenarios U Jorde, New York |
|
| Panel discussion | |
| 17:45 | Moderated poster session & welcome reception |
| Posterjury: J Gummert, E Potapov, G Färber, D Zimpfer, J Stehlik, EACTS Residents | |
| 19:15 | Close |
| 08:00 | Session 7: Guidelines on MCS: Freshly baked and still in the oven |
| Moderators: D Goldstein, G Färber, S Tucanova | |
| EACTS/STS/AATS Guidelines on Temporary Mechanical Circulatory Support (tMCS) in Cardiac Surgery P Lanmüller, Berlin |
|
| EACTS ECD on Protected Cardiac Surgery G Nersesian, Berlin |
|
| AATS surgical treatment of Acute Myocardial Infarction (AMI) complications I Potapov, Berlin |
|
| ISHLT guidelines on tMCS A Bernhardt, Hamburg |
|
| ESC heart failure update M Adamo, Brescia |
|
| Future perspective and unmet needs in clinical guidelines M Milojevic, Belgrade |
|
| 09:30 | Break |
| 10:00 | Session 8: Biventricular failure: Support or replace? |
| Moderators: F Schönrath, J Gummert, A Bernhardt | |
| Support or replace? I Netuka, Prague |
|
| Continuous-flow biventricular assist device (CF-BiVAD) with single drive lines N Dong, Wuhan |
|
| Surgical Implantation Technique for a rotary Total Artificial Heart W Cohn, Texas |
|
| CF-BiVAD with two driveline D Zimpfer, Vienna |
|
| 11:30 | Rising Stars Quiz |
| 12:15 | Lunch |
| 13:15 | Session 9: What’s in the pipeline – new devices |
| Industry updates | |
| 14:45 | Session 10: What is in the pipeline – new studies |
| Moderators: M Adamo, V Falk, J Stehlik | |
| Study 1 I Hilgendorf, Berlin |
|
| Study 2 I Just-Lauer, Berlin |
|
| Study 3 A Bernhardt, Hamburg |
|
| Study 4 To be announced |
|
| Panel discussion | |
| 15:45 | Break |
| 16:15 | Session 11: Major challenges in patients with congenital heart diseases |
| Moderators: I Adachi, J Riebandt. | |
| Failing Fontan D Zimpfer, Vienna |
|
| Paediatric support outside of traditional LVAD I Adachi, Houston |
|
| Replacement of pulmonary valve with pre-emptive use of Microaxial Flow Pump (mAFP) P Kramer, Berlin |
|
| Panel discussion | |
| 17:15 | Session 12: How I do it |
| Moderators: S Drakos, M Monteagudo-Vela, S Kore | |
| The tip of the iceberg – from driveline infection to mediastinitis Z Tucanova, Prague |
|
| Driveline relocation A Stegmann, Berlin |
|
| Left ventricle – complex anatomies and challenges in LVAD implantation A Schefer, Vienna |
|
| VAD implantation techniques with the heart transplantation perspective R Schramm, Bad Oeynhausen |
|
| Robotic LVAD implantation F Khaliel Riyadh |
|
| Panel discussion | |
| 18:15 | Close |
| 08:00 | Session 13: Combination of temporary and durable devices – effects and pitfalls |
| Moderators: P Ivak, S Drakos, R Schramm | |
| Preconditioning before dMCS J Riebandt, Vienna |
|
| Challenges during transition from mAFP to dLVAD Y Hrytsyna, Berlin |
|
| Pro and contra discussion; My first choice for tMCS in cardiogenic shock | |
| Pro ECMO M Morshuis, Bad Oeynhausen |
|
| Pro mAFP M Monteagudo-Vela, London |
|
| Rebuttal | |
| Panel Discussion and Voting | |
| 09:30 | Break |
| 10:00 | Session 14: Weaning from dLVAD |
| Moderators: A Milwidsky, R Hernandez. | |
| Wean VAD Register S Drakos, Salt Lake City |
|
| Deactivation of LVAD support G Färber, Homburg |
|
| The role of RV fibrosis in the LVAD weaning M Bonios, Athens |
|
| Panel discussion | |
| 11:00 | Session 15: The beauty and the beast – complex cases and creative solutions in cardiology and cardiac surgery |
| Moderators: I Netuka, A Schaefer | |
| TriVAD N Cholevas, Berlin |
|
| New York D Goldstein, New York |
|
| New York N Uriel, New York |
|
| Turin A Loforte, Turin |
|
| Tel-Aviv A Milwidsky, Tel-Aviv |
|
| Riyadh M Al Reshidan, Riyadh |
|
| Prague P Ivak, Prague |
|
| 12:20 | Closing Remarks |
| 12:30 | Close |

